Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-01-04
2005-01-04
Fredman, Jeffrey (Department: 1636)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C425S320000, C425S325000, C425S451400, C425S253000, C425S471000, C536S023100, C536S023500
Reexamination Certificate
active
06838256
ABSTRACT:
isolated coding sequences and to the protein sequences they code for. This invention is directed to three coding sequence of the BRCA1 gene. The three coding sequences, BRCA1(omi1), BRCA1(omi2), and BRCA1(omi3)and their frequencies of occurrence are provided together with the protein sequences they code for. Another aspect of this invention is a method of determining the consensus sequence for any gene. Another aspect of the invention is a method of identifying an individual having an increased genetic susceptibility to breast or ovarian cancer because they have inherited a causative mutation in their BRCA1 gene. This invention is also related to a method of performing gene therapy with any of the isolated BRCA1 coding sequences.
REFERENCES:
patent: 4683202 (1987-07-01), Mullis
patent: 5455934 (1995-10-01), Holland et al.
patent: 5510270 (1996-04-01), Fodor et al.
patent: 5545531 (1996-08-01), Rava et al.
patent: 5547839 (1996-08-01), Dower et al.
patent: 5561058 (1996-10-01), Gelfand et al.
patent: 5582989 (1996-12-01), Caskey et al.
patent: 5589330 (1996-12-01), Shuber
patent: 5624803 (1997-04-01), Noonberg et al.
patent: 5633134 (1997-05-01), Shuber
patent: 5650316 (1997-07-01), Aggarwal et al.
patent: 5693473 (1997-12-01), Shattuck-Eidens et al.
patent: 5710001 (1998-01-01), Skolnick
patent: 5726019 (1998-03-01), Sidranshy
patent: 5747282 (1998-05-01), Skolnick
patent: 5750400 (1998-05-01), Murphy et al.
patent: 5753441 (1998-05-01), Skolnick
patent: 5756294 (1998-05-01), White et al.
patent: 5858669 (1999-01-01), Levine
patent: 5891857 (1999-04-01), Holt et al.
patent: 5912127 (1999-06-01), Narod et al.
patent: 5948643 (1999-09-01), Rubinfeld et al.
patent: 5965377 (1999-10-01), Adams et al.
patent: 6033857 (2000-03-01), Tavtigian et al.
patent: 6045997 (2000-04-01), Futreal et al.
patent: 6051379 (2000-04-01), Lescallett et al.
patent: 6083698 (2000-07-01), Olson et al.
patent: 6124104 (2000-09-01), Tavtigian et al.
patent: 6130322 (2000-10-01), Murphy et al.
patent: 0705902 (1996-10-01), None
patent: 2307477 (1997-05-01), None
patent: WO9304200 (1993-03-01), None
patent: WO 9605306 (1996-02-01), None
patent: WO9722689 (1997-06-01), None
patent: WO9730108 (1997-08-01), None
patent: WO9815654 (1998-04-01), None
PTO sequence search report, Mar. 2004.*
Verma et al, Gene Therapy-promises, problems and prospects. NATURE 389:239-242, 1997.*
Wood. Phenotype Assesment: Are you missing something? COMP. MED. 50(1): 12-15, 2000.*
Wall RJ. Transgenic livestock: Progress and prospects for the future. THERIOGENOLOGY 45:57-68, 1996.*
Kappel et al. Regulating gene expression in transgenic animals. Current Opinion in Biotechnology 3:558-553 1992.*
Ngo, Computational complexity Protein structure prediction and the Levinthal paradox in The Protein Folding Problem and Tertiary Structure Prediction, Merz et al. (eds), Birkhauser Boston: Boston, MA, pp. 443 and 492-495, 1994).
Rudinger Characteristics of amino acids as components of a peptide hormone sequence (in Peptide Hormones, Parsons (ed.), University Park Press: Baltimore, MD, pp. 1-7, 1976).
Yassaee et al Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer. Breast Cancer Res. 2002;4(4):R6. Epub 2002 Apr. 16.*
Montagna et al Identification of BRCA1 and BRCA2 carriers by allele-specific gene expression (AGE) analysis Int J Cancer. Apr. 10, 2002;98(5):732-6.*
Rosenberg et al, Gene Therapist, Heal Thyself. SCIENCE 287:1751, 2000.*
Anderson WF, Human Gene Therapy. NATURE 392:25-30, 1998.*
Abeliovich et al. (1997) The Founder Mutations 185delAG and 5382insCin BRCA and 6174delT in BRCA2 Appear in 60% of Ovarian Cancer and 30% of Early-Onset Breast Cancer Patients among Ashkenazi Women.Am. J. Hum. Genetics60(3): 505-514.
Bertwistle et al. (1998) Functions of the BRCA1 and BRCA2 genes.Current Opinion Genet. Dev.8(1):14-20.
Friedman et al. (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.Nature Genetics8(4):399-404.
Funari et al. (1997) Growth suppression of glioma cells by PTEN requires functional phosphatase catalytic domain.Proceedings of the National Academy of Sciences(USA) 94(23): 12479-12484.
Hacia et al. (1996) Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis.Nature Genetics14(4):441-447.
Hogervorst et al. (1995) Rapid detection of BRCA1 mutations by the protein truncation test.Nature Genetics10(2): 208-212.
Husain et al. (1998) BRCA1 Up-Regulation Is Associated with Repair-mediated Resistance to cis-Diamminedichloroplatinum (II)1Cancer Research58(6): 1120-1123.
Ruffner et al. (1997) BRCA1 is a Cell Cycle-Regulated Nuclear Phosphoprotein.Proceedings of the National Academy of Sciences(USA) 94(14): 7138-7143.
Shattuck-Eidens et al. (1995) A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene.Journal of the American Medical Association273(7): 535-541.
Struewing et al. (1995) The Carrier Frequency of the BRCA1 185delAG Mutation is Approximately 1 Percent in Ashkenazi Jewish Individuals.Nature Genetics11(2):198-200.
Tashiro et al. (1997) Mutations in PTEN Are Frequent in Endomentrial Carcinoma But Rare in Other Common Gynecological Malignancies1.Cancer Research57(18): 3935-3940.
Thompson et al. (1995) Decreased Expression of BRCA1 Accelerates Growth and is Often Present During Sporadic Breast Cancer Progression.Nature Genetics9(4):444-450.
Zhang et al (1998) BRCA1, BRCA2, and DNA Damage Response: Collision or Collusion?Cell92(4): 433-436.
Allen Antonette C.
Alvares Christopher P.
Critz Brenda S.
Murphy Patricia D.
Olson Sheri J.
Fredman Jeffrey
Gene Logic Inc.
Kaushal Sumesh
Morgan & Lewis & Bockius, LLP
LandOfFree
Coding sequences of the human BRCA1 gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Coding sequences of the human BRCA1 gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coding sequences of the human BRCA1 gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3423248